Although GRK2 has thus far been the primary focus of drug discovery efforts [7,8,9,10,11], GRK5 has been increasingly targeted as a potential treatment for cardiac hypertrophy [12,13]. This evidence concerns the gene GRK5 and cardiac hypertrophy.